NVS/(ARIA)—ABL001 will be tested in combination with Gleevec and in combination with Tasigna—first data in 2015; whether this means an FDC is unclear. (Source: NVS 3Q14 CC)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.